Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report offering an extensive overview of Russia's clinical trials market in the context of other Central and Eastern European countries.
“Clinical trials in Russia 2008 Russia compared to other countries”, which is available from http://www.piribo.com/
As a supplement, the report offers a directory of Contract Research Organisations and pharmaceutical companies active in clinical trials in Russia.
Section one provides extensive information on the clinical trials market in Russia. It discusses its size and structure, as well as the number of trials and patients involved. It presents forecasts for 2008-2012 and analyses current and anticipated market growth opportunities and obstacles. It also includes information on profiles and market situation of companies active on the market in 2006 and 2007.
Section two analyses the results of a survey carried out among such research companies. It evaluates the current market situation, and presents forecasts for the year 2008. Business development opportunities and obstacles are discussed, together with market development expectations of companies for 2008-2009. It also compares Russia's clinical research environment with that of other countries in Central and Eastern Europe. Section three provides readers with essential and up-to-date information on the legal aspects of clinical research in Russia.
Section four examines basic attitudes to clinical trials in Russia.
Section five presents some basic facts on demography and healthcare in Russia, with special attention given to Russia's population, its density and the prevalence of illnesses in the country.
“Clinical trials in Russia 2008 Russia compared to other countries” is available from Piribo. For more information go to: http://www.piribo.com/
Piribo product ID: PMR011
